Results 171 to 180 of about 172,066 (333)

Prescription drug abuse: from epidemiology to public policy. [PDF]

J Subst Abuse Treat, 2015
McHugh RK, Nielsen S, Weiss RD.
europepmc   +1 more source

Evaluation of Abuse of Prescription and Illicit Drugs inChronic Pain Patients Receiving Short-Acting (Hydrocodone)or Long-Acting (Methadone) Opioids

, 2005
Laxmaiah Manchikanti
openalex   +1 more source

Prescription Drug Abuse in Canada and the Diversion of Prescription Drugs into the Illicit Drug Market [PDF]

, 2005
Emma Haydon, Jürgen Rehm, Benedikt Fischer, Neerav Monga, Edward M. Adlaf   +4 more
openalex   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Prescription drug abuse communication: A qualitative analysis of prescriber and pharmacist perceptions and behaviors. [PDF]

Res Social Adm Pharm, 2016
Hagemeier NE, Tudiver F, Brewster S, Hagy EJ, Hagaman A, Pack RP.   +5 more
europepmc   +1 more source

Nonmedical Prescription Drug Use on College Campuses: Risk Factors for Abuse

, 2010
Jennifer S. Barber
openalex   +2 more sources

Secondary analysis of a combined harm‐reduction treatment and extended‐release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth

Addiction, EarlyView.
Abstract Background and Aims In a prior randomized clinical trial (RCT), combined pharmacobehavioral harm‐reduction treatment improved alcohol outcomes and physical health‐related quality of life (PH‐QoL). In this secondary analysis, we tested race, ethnicity and sex assigned at birth as predictors and moderators of these effects.
Silvi C. Goldstein, Nicole H. Weiss, Manshu Yang, Sarah W. Feldstein Ewing, Susan E. Collins   +4 more
wiley   +1 more source

A Path Out: Prescription Drug Abuse and Suicide [PDF]

, 2016
Mark Borgschulte, Adriana Corredor‐Waldron, Guillermo Marshall   +2 more
openalex  

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

Addiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne, Will Lawn, Kat Petrilli, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H. Valerie Curran, Lindsey A. Hines, Tom P. Freeman   +9 more
wiley   +1 more source

Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era

Addiction, EarlyView.
Abstract Background Canada's 2018 legalization of non‐medical cannabis was positioned as a public health initiative, intended to shift cannabis use from criminalization to regulation. Since then, cannabis access and consumption have grown significantly but the systems used to monitor cannabis‐related harms have not kept pace.
Anees Bahji
wiley   +1 more source